023910 — Dai Han Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual cashflow statement for Dai Han Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	17,381	22,670	24,961	28,426	33,759
Depreciation
Amortisation
Non-Cash Items	16,418	10,392	11,572	12,241	9,597
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-11,472	-3,856	-16,740	-10,471	-14,995
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	33,627	40,617	28,999	38,860	35,643
Capital Expenditures	-5,360	-11,850	-8,621	-21,280	-15,801
Purchase of Fixed Assets
Other Investing Cash Flow Items	-5,577	336	8,815	3,283	-56,824
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-10,938	-11,515	193	-17,998	-72,626
Financing Cash Flow Items	-110	-61.7	—	-80	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,709	-7,408	-22,543	-10,332	-4,368
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	16,562	22,367	7,092	10,644	-40,199